Some patients still have MDS cells in their bone marrow after treatment. This is called refractory MDS. Some patients have a return of MDS cells in the marrow and a decrease in normal blood cells after remission. This is called a relapse.
Refractory MDS is typically treated with a different treatment than the first therapy used.
Relapsed MDS is typically treated with either the same treatment used before or a different standard treatment.
- Download or order The Leukemia & Lymphoma Society's free booklets
- Clinical Trials